An Intronic Growth Hormone Receptor Mutation Causing Activation of a Pseudoexon Is Associated with a Broad Spectrum of Growth Hormone Insensitivity Phenotypes
Author(s) -
Alessia David,
Cecilia CamachoHübner,
Amrit Bhangoo,
Stephen Rose,
Farideh MirakiMoud,
Scott Akker,
Gary Butler,
Svetlana Ten,
Peter Clayton,
Adrian Clark,
Martin O. Savage,
Lou Metherell
Publication year - 2006
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-1527
Subject(s) - growth hormone receptor , short stature , exon , phenotype , genetics , mutation , biology , hypoplasia , intron , gene , endocrinology , medicine , growth hormone , hormone
Inherited GH insensitivity (GHI) is usually caused by mutations in the GH receptor (GHR). Patients present with short stature associated with high GH and low IGF-I levels and may have midfacial hypoplasia (typical Laron syndrome facial features). We previously described four mildly affected GHI patients with an intronic mutation in the GHR gene (A(-1)-->G(-1) substitution in intron 6), resulting in the activation of a pseudoexon (6Psi) and inclusion of 36 amino acids.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom